In realm of pharmaceutical vestibulum, in synthesim activae intermedia utII-amino-4'-bromobenzophodoneest crucial.Jiangsu Jingye PharmaceuticalStat ad forefront huius processus, tradens summus qualis componit essential progressionem provectus pharmaceuticals.
Synonyms and Lepidium sativum
Communiter quod (II-aminophenyl) (IV-bromophenyl) Methanone, hoc compositis identified per Cas Number 1140-17-6. Est in media medialis in synthesim variis pharmaceutical agentibus.
Molecular characteres
Cum autem mocecular formula c13h10brno et molecular pondus 276,13:II-amino-4'-bromobenzophodoneEst propria ab eius aromatice benzophenone structuram, quae est adhuc mutatio per praesentiam Amino et Bromo substituents.
Processu productio
Productio processus II-amino-4'-bromobenzophodone adJiangsu Jingye Pharmaceuticalalibi a restrictius qualitas imperium mensuras. Incipiens cum summus puritas rudis materiae, in synthesis involves seriem diligenter continentur chemical reactiones, cursus in additione Bromo et amino coetus in rectam positions in Benzophenone Backbone.
Applications
Hoc compositis invenit suam applicationem per spectro de pharmaceutical conatus. Hoc serves sicut medium pro pronak et eius versatility se extendit ad consuetudinem synthesim et eget productio procedit. Eius munus est pivotal in officinarum investigationis et progressionem, conlatis ad synthesim novæ componit.
Praeprehensionem et qualitas fide
Jiangsu Jingye Pharmaceutical diligit se in esse optimum vendit huius compositum, attributing eius victoria ad altum qualitas, competitive Morbi cursus sapien, ieiunium partus, et velox responsio ad client quaestiones. De comitatu commitment ad excellentiam ensures ut quisque batch deII-amino-4'-bromobenzophodoneOccurrit summa signa puritatis et constantia.
Conclusio
Et anxius synthesis de II-amino-4 '-bromobenzophenone underscoresJiangsu Jingye Pharmaceutical's dedication ad progredientes pharmaceutical industria. Per providing hoc key medium cum superior species et reliability, in comitatu confert significantly ad salutem et bene esse de societate.If opus est, vos canContact Us: Email:guml@depeichem.com/shiyf@depeichem.com.
Post tempus: Apr-24-2024